BlackRock Advisors’s Harvard Bioscience HBIO Stock Holding History

BlackRock Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$796K	Hold	26,093	–	–	﹤0.01%	1966
2016 Q3	$710K	Buy	26,093 +206	+0.8%	+$5.72K	﹤0.01%	1993
2016 Q2	$740K	Sell	25,887 -817	-3%	-$26K	﹤0.01%	1905
2016 Q1	$806K	Sell	26,704 -352	-1%	-$9.98K	﹤0.01%	1843
2015 Q4	$939K	Sell	27,056 -359	-1%	-$12.3K	﹤0.01%	1745
2015 Q3	$1.04M	Sell	27,415 -895	-3%	-$41.6K	﹤0.01%	1666
2015 Q2	$1.61M	Sell	28,310 -66	-0.2%	-$3.76K	﹤0.01%	1374
2015 Q1	$1.65M	Sell	28,376 -272	-0.9%	-$14.6K	﹤0.01%	1307
2014 Q4	$1.62M	Buy	28,648 +6,316	+28%	+$301K	﹤0.01%	1274
2014 Q3	$913K	Buy	22,332 +122	+0.5%	+$5.61K	﹤0.01%	1482
2014 Q2	$1.01M	Sell	22,210 -4,813	-18%	-$202K	﹤0.01%	1484
2014 Q1	$1.28M	Buy	27,023 +105	+0.4%	+$4.78K	﹤0.01%	1384
2013 Q4	$1.26M	Sell	26,918 -8,397	-24%	-$367K	﹤0.01%	1369
2013 Q3	$1.41M	Buy	35,315 +131	+0.4%	+$5.15K	﹤0.01%	1269
2013 Q2	$1.25M	Buy	+35,184	New	+$1.35M	﹤0.01%	1282

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPC

Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock Advisors's HBIO Position: Q4 2016 in Review

BlackRock Advisors held its Harvard Bioscience (HBIO) position steady in Q4 2016 at 26,093 shares worth $796K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

BlackRock Advisors first reported a position in HBIO in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.65M in Q1 2015. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2016.

BlackRock Advisors held 26,093 shares of Harvard Bioscience worth $796K as of Q4 2016.
BlackRock Advisors left its Harvard Bioscience share count unchanged in Q4 2016.
Harvard Bioscience made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1966 holding.
BlackRock Advisors first reported a position in Harvard Bioscience in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Harvard Bioscience position peaked at $1.65M in Q1 2015.
68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.